成都硕德药业

Chengdu Shuode Pharmaceutical is a biopharmaceutical company specializing in the development and industrialization of complex drug delivery systems, with a core focus on long-acting injectable microspheres. Based in the Chengdu Medical City, the company utilizes its proprietary technology platforms to develop high-end improved drugs and innovative therapies for central nervous system disorders, oncology, and endocrine diseases. Shuode operates a comprehensive infrastructure that includes advanced R&D laboratories and large-scale GMP-compliant manufacturing facilities. Their lead programs include long-acting formulations of risperidone and rotigotine, aimed at improving patient adherence in chronic disease management. The company positions itself as a leader in the domestic Chinese market for complex injectables while exploring global opportunities for its formulation expertise.